Biology Reference
In-Depth Information
Hanada K, Tamai M, Yamagish M (1978) Isolation and characterization of E-64, a new thiol
protease inhibitor. Agric Biol Chem 42:523-528
He GA, Luo JX, Zhang TY, Wang FY, Li RF (2003) Canstatin-N fragment inhibits in vitro
endothelial cell proliferation and suppresses in vivo tumor growth. Biochem Biophys Res
Commun 312:801-805
Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL (1997) Initiation of
osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22058
Hou WS, Li Z, Gordon RE, Chan K, Klein MJ, Levy R, Keysser M, Keyszer G, Bromme D (2001)
Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation. Am J
Pathol 159:2167-2177
Hou W-S, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme
D (2002) Comparison of cathepsins K and S expression within the rheumatoid and osteoar-
thritic synovium. Arthritis Rheum 46:663-674
Hou WS, Li Z, Buttner FH, Bartnik E, Bromme D (2003) Cleavage site specificity of cathepsin K
toward cartilage proteoglycans and protease complex formation. Biol Chem 384:891-897
Isemura M, Yosizawa Z, Takahashi K, Kosaka H, Kojima N, Ono T (1981) Characterization of
porcine plasma fibronectin and its fragmentation by porcine liver cathepsin B. J Biochem
90:1-9
Ishidoh K, Kominami E (1995) Procathepsin L degrades extracellular matrix proteins in the
presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 217:624-631
Jedeszko C, Sloane BF (2004) Cysteine cathepsins in human cancer. Biol Chem 385:1017-1027
Jordans S, Jenko-Kokalj S, Kuhl NM, Tedelind S, Sendt W, Bromme D, Turk D, Brix K (2009)
Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physio-
logical pH and redox conditions. BMC Biochem 10:23
Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP (1998) Human cathepsin K
cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J
331:727-732
Kamiya T, Kobayashi Y, Kanaoka K, Nakashima T, Kato Y, Mizuno A, Sakai H (1998)
Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal
cysteine proteinase in osteoclasts. J Biochem 123:752-759
Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier
JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogene-
sis and tumor growth. J Biol Chem 275:1209-1215
Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML (2005) An overview of matrix
metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc
Endovasc Surg 39:457-464
Kim TS, Tasker AS (2006) Non-covalent cathepsin K inhibitors for the treatment of osteoporosis.
Curr Top Med Chem 6:355-360
Kirschke H, Schmidt I, Wiederanders B (1986) Cathepsin S. The cysteine proteinase from bovine
lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15). Biochem J 240:455-459
Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, Duramad P, Sun C, Zhang Y, Yang X,
Peters C, Shi GP (2007) Cathepsin L deficiency reduces diet-induced atherosclerosis in low-
density lipoprotein receptor-knockout mice. Circulation 115:2065-2075
Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljestrom M, Hukkanen M, Takagi M,
Virtanen I, Santavirta S (2002) Acidic cysteine endoproteinase cathepsin K in the degen-
eration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum
46:953-960
Lackman RL, Jamieson AM, Griffith JM, Geuze H, Cresswell P (2007) Innate immune recognition
triggers secretion of lysosomal enzymes by macrophages. Traffic 8:1179-1189
Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloan BF (1989) Degradation of
laminin by human tumor cathepsin B. Clin Exp Metastasis 7:461-468
Lane TF, Sage EH (1994) The biology of SPARC, a protein that modulates cell-matrix interac-
tions. FASEB J 8:163-173
